Application of the Fugl-Meyer Assessment (FMA) and the Wolf Motor Function Test (WMFT) in the recovery of upper limb function in patients after chronic stroke: a literature review by Padovani, Cauê et al.
42
RE
V
IE
W
 A
RT
IC
LE
ABSTRACT
It is estimated that 45-75% of chronic adult stroke patients have difficulty in using the hemiparetic upper limb (MS) in 
their daily life activities (DLAs). Functional scales are used in the practice of rehabilitation, in the search for diagnoses 
and prognoses, and in evaluating response to treatment. The Wolf Motor Function Test (WMFT) and Fugl-Meyer As-
sessment (FMA) scales are the instruments most commonly mentioned in the literature. Objective: The aim of this 
study was to review the use of the WMFT and FMA scales in the recovery of upper limb function in patients after 
chronic stroke. Method: We searched the MedLine database (PubMed) for articles published from 2000 to 2013. The 
PICO method was adopted as the search strategy. The descriptors used for the search were: (stroke OR cerebrovas-
cular disorders OR intracranial arteriosclerosis OR thrombosis intracranial embolism) AND (Fugl-Meyer assessment 
OR wolf motor function test). Therapy/narrow was used as a search filter. Results: We found 181 studies, 89 of which 
were excluded because they did not meet the inclusion criteria or did not have a topic relevant to the review search. 
After selection by title and by abstract, 92 articles were fully read. Of these articles, 47 were excluded because they 
did not fulfil the search objective. All in all, 45 articles were reviewed. FMA is the tool most used and it was found that 
80% of the studies applied this scale to evaluate responses to the different therapies. In these studies, the interven-
tion most used was the Constrained Induced Therapy (CIT) (25%), followed by Robotics Therapy (22.2%). Although the 
WMFT was initially developed to assess the effects of CIT, nowadays this scale is used, after the application of other 
techniques, to assess the functional recovery of patients with stroke sequelae. In our survey, 44.4% of the studies 
used WMFT; of these, 35% assessed the effects of CIT, 15% assessed robotic therapy for the upper limbs, and 65% for 
different therapies. Conclusion: For randomized controlled trials, the FMA scale was more used to assess functional 
recovery in the upper limbs of chronic stroke patients, even after application of robotics therapy. However, we found 
that it is not the most appropriate scale to assess the same outcomes after CIT use. WMFT is the scale most widely 
used for functional assessment after application of CIT; it is more sensitive than FMA for bilateral therapy, and is highly 
applicable in virtual reality therapy.
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INTRODUCTION
Strokes are a major public health problem 
and one of the main causes of death and long 
term disability.1,2,3
Studies estimate that its worldwide preva-
lence is of 5 to 10 cases per 1,000 inhabitants.4 
The incidence of stroke doubles with every 
decade of life from the age of 55, however, 
this has been changing as the presence of 
predisposing factors is growing and, more 
and more, this neurological condition affects 
a larger number of young people.5,6
Stroke is considered the most common 
neurological illness in clinical practice, leading 
to neurological deficits such as total or partial 
paralysis of the hemibody (hemiplegia and he-
miparesis), in addition to compromising the 
visual, sensory, and cognitive fields, as well as 
communication/speech.2,5,7
Up to 85% of patients have shown hemipa-
resis immediately after a stroke, and between 
55% and 75% of the survivors continued ex-
periencing associated motor deficits, many 
times resulting in losses that could limit their 
autonomy in daily life activities (DLAs) and 
their quality of life.5,8,9
Normally, the capacity for the central con-
trol of movement shows severe impairment 
due to the damages caused by the stroke to 
the neural mechanisms that control voluntary 
movement. These damages lead to weakness 
and alterations in muscular tone and stereo-
typed movement synergies, which collectively 
limit functioning. Stroke survivors many times 
perform tasks through compensating move-
ment strategies. These compensations are 
considered prejudicial to the recovery of the 
capacity for voluntary movement.3,10
Approximately 45% to 75% of adults who 
have suffered a stroke have difficulty using 
their hemiparetic upper limb (UL) in the DLAs 
during their chronic phase.11,12 Many studies 
in the area of neurological rehabilitation 
demonstrate the incentive of techniques 
and protocols for intensive training aiming 
to improve the function of the compromised 
upper limb.
Functional scales are used in the rehabi-
litation practice for diagnostics, prognostics, 
and responses to treatments. The Wolf 
Motor Function Test (WMFT) and Fugl-Meyer 
Assessment (FMA) are instruments widely 
mentioned in the literature.1,11,13
The WMFT was initially developed to 
evaluate the effects of Constraint-Induced 
Movement Therapy (CIMT) in individuals 
with hemiparesis. The original version was 
composed of 21 sequenced tasks specific to 
the articulations involved (from the shou-
lder to the fingers) and level of difficulty 
(from gross to fine motor activity), evalua-
ting the function of the upper limb through 
one or multiple articular movements and 
functional tasks. This test was later modified 
to a version with 17 sequential tasks to sim-
plify its application. The WMFT evaluates 
the speed of execution of the task, quanti-
fies the quality of movement via a scale of 
functional ability, and measures the shoul-
der prehension and flexion strength in two 
specific tasks.11,12,14
Developed by Fugl-Meyer et al,15 the FMA 
was the first quantitative instrument for sen-
sory-motor measurement in the recovery 
after a stroke, and it is probably the best-k-
nown and used scale in research and clinical 
practice. The FMA is characterized as a cumu-
lative numerical score system that evalua-
tes six aspects of the patient: amplitude of 
movement, pain, sensitivity, motor function 
of upper and lower limbs, and balance, in ad-
dition to coordination and speed. The motor 
evaluation includes measuring the movement, 
coordination, and the reflex activity of the 
shoulder, elbow, wrist, hand, hip, knee, and 
ankle. This scale has a total of 100 points for 
the normal motor function, in which the maxi-
mum score for the upper limb is 66 and for the 
lower limb is 34.1,5
In this context, the importance of correctly 
choosing the functional evaluation instrument 
for post-stroke patients is confirmed, optimi-
zing the rehabilitation process.
OBJECTIVE
The objective of the present study was 
to verify the use of the Wolf Motor Function 
Test and the Fugl-Meyer Assessment in 
controlled and randomized clinical studies in 
the functional recovery of the upper limb in 
chronic post-stroke patients.
METHODS
A literature review was made searching 
the MedLine (PubMed) database for arti-
cles published from 2000 to 2013. The PICO 
method was adopted as a research strate-
gy, it is the acronym formed by the initials 
of the words Patient, Intervention, Control, 
and Outcome. The descriptors used for the 
research were: (stroke OR cerebrovascular 
disorders OR intracranial arteriosclerosis 
OR intracranial embolism and thrombosis) 
AND (Fugl-Meyer assessment OR wolf motor 
function test). The search filter used was 
“therapy/narrow”.
The selection of articles followed the 
following inclusion criteria:
1. articles were published in English or 
Portuguese;
2. they used the WMFT and/or FMA scales 
in the methodological procedures;
3. sampled individuals were over 18 
years of age;
4. chronic stroke (≥ 3 months) was the 
profile for time of lesion;
5. clinical tests were the type of study; 
and
6. the studies evaluated the effect of a 
rehabilitation technique having the 
functioning of upper limbs as the 
outcome.
Articles were excluded in the following 
situations:
1. isolated effects of medication therapy 
and/or surgical procedures;
2. ongoing studies;
3. acute or subacute stroke for the time 
of lesion;
4. studies that had no relationship to 
the function of the upper limbs; and
5. studies of low quality (JADAD < 3).16
After the selection, the articles inclu-
ded were read completely and evaluated 
through the JADAD scale, which has a score 
from 1 to 5. The studies were classified as 
having good quality, for JADAD ≥ 3 and low 
quality for JADAD < 3.
The descriptive statistic was presented in 
the form of frequency (%), average (A), and 
standard deviation (SD). The data obtained 
was tabulated in spreadsheets in the Microsoft 
Office Excel® 2007 program.
RESULTS
After searching the Medline database, 89 
of the 181 studies found were eliminated for 
not meeting the inclusion criteria or for not 
having a theme relevant to the study. After se-
lecting by title and abstract, 92 articles were 
read completely. Of those, 47 were excluded 
for not addressing the objective of the present 
study (Table 1); overall, 45 articles were re-
viewed. The organizational chart below details 
the selection process of the studies (Figure 1). 
The summary of the studies is described in 
Table 2.
Table 2 below details the reasons for ex-
clusion from the studies that did not enter in 
this review.
Acta Fisiatr. 2013;20(1):42-49 Padovani C, Pires CVG, Ferreira FPC, Borin G, Filippo TRM, Imamura M, et al.
Application of the Fugl-Meyer Assessment (FMA) and the Wolf Motor Function Test (WMFT) in the recovery of 
upper limb function in patients after chronic stroke: a literature review 
44
The quality classification of the studies in 
the JADAD scale that scored ≥ 3 and the coun-
tries where the studies were developed are 
described in Tables 3 and 4, respectively.
According to the inclusion criteria, all the 
reviewed articles used the WMFT and/or the 
FMA. Many studies also used other scales. The 
scales used are described in Table 5.
In all, 23 types of therapy were applied 
in the articles, combined with conventional 
therapy or not (Table 6).
The average time of treatment was 
35.47 ± 26.77 days, with an average of 5.12 ± 
2.21 days per week. The average age of the po-
pulation in the studies was 60.75 ± 3.68 years.
DISCUSSION
In order to better understand the im-
pact of strokes, it is important to incorporate 
evaluative measurements of the disabilities 
provoked by this condition. In recent years, 
functional evaluation scales have been de-
veloped and used in rehabilitation and in 
research for diagnostics, prognostics, and 
responses to treatments. Physiotherapeutic 
evaluation uses functional scales to monitor 
the clinical evolution and recovery of the pa-
tient with stroke sequelae. Normally, it mea-
sures sensory-motor function impairments, 
especially the independence in the DLAs.1,2,62
In our research, we found predominan-
ce in the use of the FMA tool. We found that 
80% of the studies used this scale to evaluate 
the responses to different types of therapies. 
In those studies, the most used intervention 
was CIMT (25%), followed by robotics therapy 
(22.2%).
The FMA is the preferred measuring 
scale for studies, for its validity has already 
been established. The scale was accepted in-
ternationally due to its easy application and 
appropriate measuring of motor recovery in 
rehabilitation. The instructions are relatively 
direct and simple and the evaluation does 
not demand any special equipment, contrary 
to other evaluation scales.1,63 In addition, stu-
dies on the validation of the FMA have clearly 
shown a high intra-observer and inter-obser-
ver reliability, among chronic patients as well 
as in acute post-stroke patients.64
When compared to other scales such as 
the Functional Independence Measure (FIM) 
and Functional Test for the Hemiplegic Upper 
Extremity (FTHUE), the FMA was the most ef-
fective in evaluating functional recovery after 
the application of FES on the impaired limb 
Table 1. Exclusion criteria of articles
Reasons Included (45) Excluded Excluded (%)
JADAD (< 3) - 20 13.16
Sub-acute/acute stroke - 45 29.61
In progress - 3 1.97
Not available online - 5 3.29
Lower limb evaluation - 16 10.53
Divergent outcome - 34 22.37
Different language - 15 9.87
Other types of study - 4 2.63
Published before 2000 - 6 3.95
Did not use scales - 4 2.63
Total - 152 100.00
Figure 1. Organizational chart of the study
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Table 2. Summary of the articles
Author and Year Country Evaluation Instrument Therapy
Wu CY et al. 201317 Taiwan FMA Conventional, CIMT
Linder SM et al. 201218 USA FMA, WMFT, ARAT, SIS Conventional, Robotics
Hsieh et al. 201219 Taiwan FMA, MAL, SIS, MRC Robotics
Zhuang LX et al. 201220 China FMA, Barthel Conventional, Acupuncture
Han C et al. 201321 China FMA, ARAT, Barthel Conventional
Jeon HS et al. 201222 Korea FMA, BBT, ARAT Conventional, SaeboFlex orthosis
Nilsen DM et al. 201223 USA FMA, JTHFT, COPM Conventional, Mental practice
Wu CY et al. 201224 Taiwan FMA, MAL, SIS, MAS Conventional, Robotics
Page SJ et al. 201225 USA FMA, AMAT, ARAT, BBT RTP, ESN
Huseyinsinoglu BE et al. 201226 Turkey WMFT, MAL, FIM, MESASP Bobath, CIMT
Wolf SL et al. 201127 USA WMFT, MAS, SIS Conventional, Botulin Toxin
Kiper P et al. 201128 Italy FMA, MAS, FIM Conventional, RFVE
Conroy SS et al. 201129 USA FMA Robotics
Liao WW et al. 201230 Taiwan FMA, FIM, MAL, ABILHAND Scale Conventional, Robotics
Bolognini N et al. 201131 USA FMA, MAL, JTHFT, Barthel Transcranial stimulation, CIMT
Hsieh YW et al. 201132 Taiwan FMA, MRC, MAL, ABILHAND Scale Conventional, Robotics
Page PJ et al. 201133 USA FMA, ARAT Mental practice, Specific task
Wu CY et al. 201034 Taiwan FMA, ARAT, MAL CIMT, Bilateral therapy
Lindenberg R et al. 201035 USA FMA, WMFT Conventional, Brain Electromagnetic Stimulation
Michielsen ME et al. 201136 Holland FMA, ARAT, ABILHAND Scale, EQ-5D Mirror therapy
Wu CY et al. 201137 Taiwan WMFT, MAL CIMT, Bilateral therapy
Globas C et al. 201138 Switzerland FMA, WMFT Conventional, Bilateral therapy, Auditory rhythmic stimulation
Whitall J et al. 201039 USA FMA, WMFT Conventional, Bilateral therapy, Auditory rhythmic stimulation
Saposnik G et al. 201040,41 Canada WMFT, SIS, BBT Virtual reality, Recreational therapy
Lo AC et al. 201042 USA FMA, WMFT, SIS Conventional, Robotics
Lin KC et al. 201043 Taiwan FMA, FIM, MAL Conventional, Bilateral therapy
Lo AC et al. 200944 USA FMA, WMFT, SIS, BBT Conventional, Robotics
Chae J et al. 200945 USA FMA, AMAT FES
Lin KC et al. 200946 Taiwan FMA, MAL, SIS, FIM CIMT, Bilateral therapy
Chan MC et al. 200947 Hong Kong FMA, MAS, FTHUE, FIM Conventional, FES, Bilateral therapy
Lin KC et al. 200948 Taiwan FMA, FIM, MAL, SIS Conventional, CIMT
Park SW et al. 200849 Korea FMA, WMFT, MAL, MAS CIMT, Repeated tasks
de Kroon JR et al. 200850 Holland FMA, ARAT Electrical Stimulation
Page SJ et al. 200851 USA FMA, ARAT, MAL Conventional, CIMT
Wolf SL et al. 200852 USA WMFT, MAL, SIS CIMT
Malcolm MP et al. 200753 USA WMFT, MAL, BBT Conventional, CIMT
Page SJ et al. 200754 USA FMA, ARAT Mental Practice
Fischer Hc et al. 200755 USA FMA, WMFT, BBT, RLA Conventional, Pneumatic Orthosis
Richard L et al. 200656 USA WMFT, MAL Conventional, CIMT
Wolf SL et al. 200657 USA WMFT, MAL CIMT
Pang MY et al. 200658 Canada FMA, WMFT, MAL Conventional, Therapeutic Groups
Kondziolka D et al. 200559 USA FMA, SIS, ARAT Conventional, Neuronal Transplant
Nadeau SE et al. 200460 USA FMA, WMFT, MAL, BBT Donepezil, CIMT
Page et al. 200461 USA FMA, ARAT, MAL Conventional, modified CIMT
AMAT: Arm Motor Ability Test; RTP: Repetitive task specific practice; ESN: Electrical Stimulation Neuroprothesis; CIMT: Constraint-Induced Movement Therapy; RFVE: Reinforced feedback in virtual environment; 
FES: Functional Electrical Stimulation; FMA: Fugl-MeyerAssessment; WOLF: Wolf Motor Function Test; ARAT: Action Research Arm Test; MAL: Motor Activity Log; SIS: Stroke Impact Scale; BBT: Box and Block Test; 
FIM: Functional Independence Measure; MT: Mirror Therapy; BRS-H: Brunnstrom Hand Manipulation; MRP: Motor Relearning Program; JTHFT: Jebsen-Taylor Hand Function Test; RLA: Rancho Los Amigos; COPM: Canadian 
Occupational Performance Measure; SBT: Sirigu Break Test; MAS: Modified Ashworth Scale; MESASP: Motor Evaluation Scale for Arm in Stroke Patients; AMPS: Assessment of Motor and Process Skills; MSS: Motor Status Scale; 
MRC: Medical Research Council; EQ-5D: EuroQol Group Index; FTHUE: Functional Test of the Hemiparetic Upper Extremity.
Acta Fisiatr. 2013;20(1):42-49 Padovani C, Pires CVG, Ferreira FPC, Borin G, Filippo TRM, Imamura M, et al.
Application of the Fugl-Meyer Assessment (FMA) and the Wolf Motor Function Test (WMFT) in the recovery of 
upper limb function in patients after chronic stroke: a literature review 
46
upper limb robotics therapy, and 65% used di-
fferent therapies. In the Saposnisk et al.40 stu-
dy involving the Virtual Reality technique, the 
WMFT showed more sensitivity when compa-
red to the other scales used, such as BBT and 
SIS. This growth and expansion in the use of 
the WMFT may be justified for it including a 
gamut of movements useful as much in clinical 
evaluation as in research.
Whitallet al.39 compared the functional 
benefits promoted by the Bilateral Therapy 
and CIMT techniques by using the WMFT and 
FMA scales. Both scales showed improvement 
of the paretic upper limb function of patients 
with chronic stroke. However, the WMFT 
showed more quantitative significance when 
compared to the FMA. According to Pereira 
et al.11 the FMA evaluates only movement 
components, while the WMFT is the only test 
that combines time and quality measure-
ments in the execution of the movement, in 
isolated movements of specific articulations 
as well as in complex functional tasks, being 
an evaluation applicable to patients with va-
rious levels of impairment. Other advantages 
of the WMFT are that it also includes a bima-
nual task and uses common daily materials, 
in contrast to the ARAT, which uses wooden 
cylinders and blocks, materials with little envi-
ronmental validity for they are not real objects 
in the daily life.
In a comparative study on sensitivity and 
validity of the FMA, WMFT, and ARAT scales, 
Hsieh et al.68 verified that the FMA and the 
WMFT showed more sensitivity to detect 
functional gains of the upper limb in patients 
who underwent rehabilitation after a stroke. 
In that study, the subjects were randomized 
to receive three types of rehabilitation: CIMT, 
bilateral manual therapy, and conventional 
therapy; however, there was no correlation 
between the sensitivity of the scales and the 
type of therapy.
Although the FMA and WMFT scales 
evaluate domains concerning the upper limb 
function, currently studies have been using 
an association of broader scales, such as the 
FIM, which includes, for example, the evalua-
tion of the patient’s cognitive aspects, expan-
ding the observation of potential therapeutic 
outcomes. The FIM has been widely used to 
evaluate independence in the DLAs of patients 
with stroke sequelae.68,69
The FIM was developed in 1986 by Gran-
ger et al.68 and validated in Brazil in 2000 by 
Riberto et al.70 representing good cultural 
equivalence and reproducibility. It is widely 
used and internationally accepted as a func-
tional evaluation measurement.2,10 This instru-
Table 3. Classification of the studies according to JADAD
JADAD N %
3 20 44.44
4 16 35.56
5 9 20.00
TOTAL 45 100.00
N: Total number of articles evaluated (≥ 3 good quality)
Table 4. Countries related to the development of the studies included
Countries N %
Taiwan 10 22.22
USA 22 48.89
Canada 3 6.67
China 2 4.44
Holland 2 4.44
Korea 2 4.44
Hong Kong 1 2.22
Turkey 1 2.22
Italy 1 2.22
Switzerland 1 2.22
Total 45 100.00
N: Total number of articles evaluated
Table 5. Scales used in the articles
SCALES N %
FMA 36 26.47
WMFT 20 14.71
ARAT 10 7.35
MAL 17 12.50
SIS 10 7.35
BBT 8 5.88
FIM 3 2.21
Others 32 23.53
Total 136 100.00
FMA: Fugl-Meyer Assessment; WOLF: Wolf Motor Function Test; ARAT: Action Research Arm Test; MAL: Motor Activity Log; SIS: Stroke Impact Scale; 
BBT: Box and Block Test; FIM: Functional Independence Measure
of chronic stroke patients.44 In contrast, Lin 
et al.46 explained that the use of the FMA was 
less effective in evaluating functional recovery 
after the application of CIMT, when compared 
to other scales such as the FIM, Motor Activity 
Log (MAL) andthe Stroke Impact Scale (SIS).46
The WMFT is another instrument also wi-
dely used to evaluate the function of the upper 
paretic limb in post-stroke adults. It is a scale 
that evaluates motor deficit through quantita-
tive variables, performance in time, and con-
current fine coordination and fluidity, among 
other clinically relevant characteristics.11,65
The test consists of 17 tasks that must be 
done with the limb impaired by paresis. Each 
one of the tasks is timed so as to evaluate 
the dexterity of the patient in the execution 
of each activity, comparing the median of the 
times registered for each one of the tasks. 
These tasks must be filmed with a camera pla-
ced at a standard position and distance, and 
the score is given based on an analysis of the 
videos. Video observation has shown to be a 
reliable means to evaluate time and quality of 
movement.11,66,67
Despite the WMFT having been initially 
developed to evaluate the effects of CIMT, 
nowadays it is used to evaluate the functional 
recovery of patients with stroke sequelae af-
ter the interventions. In our research, 44.4% 
of the studies used the WMFT, and of those, 
35% evaluated the effects of CIMT, 15% the 
47
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Table 6. Therapies applied in the studies
THERAPY N N (%) FMA WMFT
Conventional 26 30.95 24 9
Constraint-Induced Movement Therapy 15 17.86 9 7
Robotics 8 9.52 8 3
Bilateral therapy 7 8.33 6 3
Mental practice 3 3.57 3 0
Orthosis 2 2.38 2 1
Transcranial stimulation 2 2.38 1 1
Auditory Rhythmic Stimulation 2 2.38 2 2
Virtual reality 2 2.38 0 2
Recreational therapy 2 2.38 0 2
FES 2 2.38 2 0
ESN 1 1.19 1 0
Bobath 1 1.19 0 1
RFVE 1 1.19 0 1
Botulin toxin 1 1.19 0 1
RTP 1 1.19 1 0
Specific therapy 1 1.19 1 0
Acupuncture 1 1.19 1 0
Electromagnetic brain stimulation 1 1.19 1 1
Mirror therapy 1 1.19 1 0
Repeated tasks 1 1.19 1 1
Electrical stimulation 1 1.19 1 0
Exercises, therapeutic groups Upper and Lower Limbs 1 1.19 1 1
Donepezil 1 1.19 1 1
TOTAL 84 100.00 67 37
FES: Functional Electrical Stimulation; ESN: Electrical stimulation neuroprothesis; RFVE: Reinforced feedback in virtual environment; RTP: Repetitive 
task specific practice
ment was developed to measure functional 
capacity through a seven-level scale that re-
presents the degrees of functioning, ranging 
from independence to dependence. The clas-
sification of an activity in terms of dependen-
ce or independence is based on whether an 
individual needs to be assisted by another 
person, whether that help is necessary, and 
how much so. The FIM is an instrument that 
evaluates functional independence, regardless 
of the physical, communicative, functional, or 
emotional sequelae, among others shown by 
patients.2,10,67
Nevertheless, the literature still needs ins-
truments that evaluate the individual more 
generally, in all his or her complexity, including 
the environment in which the patient is inser-
ted and the other aspects related to their func-
tional state. Currently, the International Classi-
fication of Functioning, Disability and Health 
(ICF) is regarded as an instrument capable of 
including functional aspects associated to con-
textual factors (environmental and social),71,72 
and to allow the standardization and unifica-
tion of the professional language in the func-
tional classification of individuals, healthy or 
not. The ICF defines the domains of health 
and the domains related to health. They are 
described from the perspective of the body, of 
the individual, and of the society in two essen-
tial parts: (1) Functions and Structures of the 
Body, and (2) Activities and Participation. The 
ICF also relates the environmental factors that 
interact with all these concepts. In that sense, 
the instrument allows the registration of use-
ful profiles of the functioning, disability, and 
health of the individuals in various domains.73
The ICF has concepts coherent with some 
specific scales for post-stroke patients.74 Using 
the ICF in 2004, Geyh et al.75 developed a 
specific Core Set for patients with stroke se-
quelae, the result of a consensus among 36 
specialists from 12 different countries. In the 
study by Paanalahti et al.76 the ICF (stroke core 
set) was applied to 22 chronic post-stroke pa-
tients to evaluate their prognoses, comparing 
them with the improvement prospects repor-
ted by the patients themselves. According to 
the score of the codes, it was seen that the ICF 
correlated with the reports in all the patients’ 
aspects, including functioning.
The ICF is a very recent classification and 
is still evolving. Although promising, its use 
in clinical practice is not completely consoli-
dated. Studies are being developed to assure 
its employment and efficacy in the functional 
evaluation and classification of patients, inclu-
ding those with stroke sequelae.
As to the scales and/or instruments for 
evaluating functional recovery, another im-
portant characteristic is that the majority of 
these instruments does not consider the life 
history of the patient or his or her abilities and 
affinities.
The therapy chosen can either generate a 
positive impact, if there is a motivational link 
to the proposed intervention, or a negative 
impact, if the activity is neither pleasurable 
nor interesting to the patient. For a higher 
effectiveness of the rehabilitation process 
and functional recovery evaluation, therapis-
ts must be aware of the patient’s functioning 
in their daily context involving cognitive and 
social aspects. The patient must acquire the 
capacity to plan and organize his or her daily 
life activities and to recover a place in society.
CONCLUSION
The Fugl-Meyer Assessment was the most 
widely-used scale to evaluate the functional 
recovery of the upper limb in chronic stroke 
patients, even after the application of robo-
tics therapy. However, we confirmed that it 
was not the most suitable scale to evaluate 
the same outcomes after the use of CIMT. In 
contrast, the WMFT was the most widely used 
instrument for functional evaluation after 
CIMT. The test was more sensitive than the 
FMA in bilateral therapy, in addition to it being 
highly applicable to virtual reality therapy.
More comprehensive scales such as FIM, 
which evaluates the functional capacity and 
independence for daily life activities, and 
the ICF, which includes functional aspects 
associated with social and environmental 
factors, are being more and more studied and 
used and are gaining more prominence in the 
evaluation of functional recovery of chronic 
stroke patients.
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